These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7541356)

  • 21. The digital rectal examination (DRE) remains important - outcomes from a contemporary cohort of men undergoing an initial 12-18 core prostate needle biopsy.
    Palmerola R; Smith P; Elliot V; Reese CT; Mahon FB; Harpster LE; Icitovic N; Raman JD
    Can J Urol; 2012 Dec; 19(6):6542-7. PubMed ID: 23228289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of serum free prostate specific antigen in the screening of prostate cancer.
    Higashihara E; Nutahara K; Kojima M; Okegawa T; Miura I; Miyata A; Kato M; Sugisaki H; Tomaru T
    J Urol; 1996 Dec; 156(6):1964-8. PubMed ID: 8911366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men.
    Catalona WJ; Richie JP; Ahmann FR; Hudson MA; Scardino PT; Flanigan RC; DeKernion JB; Ratliff TL; Kavoussi LR; Dalkin BL; Waters WB; MacFarlane MT; Southwick PC
    J Urol; 2017 Feb; 197(2S):S200-S207. PubMed ID: 28012755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relative contribution of digital rectal examination and transrectal ultrasonography in interpreting serum prostate-specific antigen values for screening prostate cancer in Arab men.
    Sheikh M; Sinan T; Kehinde EO; Hussein AY; Anim JT; Al-Hunayan AA
    Ann Saudi Med; 2007; 27(2):73-8. PubMed ID: 17356323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of prostate cancer in aging males receiving PSA (prostate specific antigen) screening test (A campaign for celebration of Siriraj Established Day).
    Srinualnad S; Charoenkraikamol C; Toraksa S; Uiprasertkul M; Amornvesukit T; Taweemonkongsap T; Udompunturak S; Nualyong C; Tantiwong A
    J Med Assoc Thai; 2006 Jan; 89(1):37-42. PubMed ID: 16583579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening.
    Catalona WJ; Smith DS; Wolfert RL; Wang TJ; Rittenhouse HG; Ratliff TL; Nadler RB
    JAMA; 1995 Oct; 274(15):1214-20. PubMed ID: 7563511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of digital rectal examination and prostate specific antigen in early detection of prostate cancer.
    Galić J; Karner I; Cenan L; Tucak A; Hegedus I; Pasini J; Bilandzija-Peranović M; Mihaljević S
    Coll Antropol; 2003; 27 Suppl 1():61-6. PubMed ID: 12955893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate cancer screening in Tyrol, Austria: experience and results.
    Horninger W; Reissigl A; Rogatsch H; Volgger H; Studen M; Klocker H; Bartsch G
    Eur Urol; 1999; 35(5-6):523-38. PubMed ID: 10325519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of prostatic specific antigen in prostate cancer screening in the community.
    Jubelirer SJ; Tierney JP; Oliver S; Serrato JM; Farra S; Plymale J; Hodge E
    W V Med J; 1994 Apr; 90(4):140-2. PubMed ID: 7516602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serum prostate specific antigen for the early detection of prostate cancer in outpatients of internal medicine].
    Otani T; Hayashi Y; Ikuno Y; Hirao Y; Ozono S; Okajima E
    Hinyokika Kiyo; 1996 Sep; 42(9):645-9. PubMed ID: 8918662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of prostate cancer among men aged 40+ living in Osman Gazi health care district.
    Çeber E; Şimşir A; Umar DÇ; Karababa AO; Günaydın G; Çal Ç; Özentürk G
    Asian Pac J Cancer Prev; 2010; 11(2):473-8. PubMed ID: 20843136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Digital rectal examination is barrier to population-based prostate cancer screening.
    Nagler HM; Gerber EW; Homel P; Wagner JR; Norton J; Lebovitch S; Phillips JL
    Urology; 2005 Jun; 65(6):1137-40. PubMed ID: 15922431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate-specific antigen and digital rectal examination in screening for prostate cancer: a community-based study.
    Bretton PR
    South Med J; 1994 Jul; 87(7):720-3. PubMed ID: 7517580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements.
    Catalona WJ; Smith DS; Ornstein DK
    JAMA; 1997 May; 277(18):1452-5. PubMed ID: 9145717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
    Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A
    J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study on the prevalence of clinically detectable prostate cancer in patients with and without bladder cancer.
    Kurokawa K; Ito K; Yamamoto T; Takechi H; Miyamoto S; Suzuki K; Yamanaka H
    Urology; 2004 Feb; 63(2):268-72. PubMed ID: 14972469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of digital rectal examination on serum prostate-specific antigen in a primary care setting. The Internal Medicine Clinic Research Consortium.
    Arch Intern Med; 1995 Feb; 155(4):389-92. PubMed ID: 7531426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinoma.
    el-Galley RE; Petros JA; Sanders WH; Keane TE; Galloway NT; Cooner WH; Graham SD
    Urology; 1995 Aug; 46(2):200-4. PubMed ID: 7542822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relationship between screening by stratifying cases into groups on prostate specific antigen level and the positive rate of transrectal ultrasound guided systematic sextant prostate biopsy].
    Cao XL; Gao JP; Han G; Tang J; Hong BF
    Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(6):372-5. PubMed ID: 16638344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns in prostate-specific antigen test use and digital rectal examinations in the Behavioral Risk Factor Surveillance System, 2002-2006.
    Ross LE; Taylor YJ; Richardson LC; Howard DL
    J Natl Med Assoc; 2009 Apr; 101(4):316-24. PubMed ID: 19397221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.